National Stock Number (NSN) Output Data
NSN:
NIIN:
Item Name:
CLONAZEPAM TABLETS , USP
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| KLONOPIN | 66002 | A | 5 | 1 | 4 | ZZ | ||
| NDC00591-0746-01 | 62051 | A | 5 | 2 | 4 | ZZ | ||
| NDC00004-0068-45 | 04493 | A | 5 | 9 | 4 | KX | ||
| 71816 | 04493 | A | 3 | 2 | 4 | KX | ||
| NDC00093-0832-01 | 3V8D7 | A | 5 | 2 | 4 | ZZ | ||
| NDC00378-1910-01 | 60895 | A | 5 | 2 | 4 | ZZ | ||
| NDC00228-3003-11 | 1SFA8 | A | 5 | 2 | 4 | ZZ | ||
| NDC00004-0068-01 | 66002 | A | 3 | 2 | 4 | ZZ | ||
| KLONOPIN | 04493 | A | 5 | 1 | 4 | KX |
CAGE Information
| Code | Company |
|---|---|
| 04493 | HOFFMANN-LA ROCHE INC. |
| 66002 | ROCHE LABORATORIES INC. |
| 62051 | DANBURY PHARMACAL INC |
| 3V8D7 | TEVA PHARMACEUTICALS USA INC. DBA GA |
| 60895 | MYLAN PHARMACEUTICALS INC |
| 1SFA8 | ALPHARMA US PHARMACEUTICALS DIVISION |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| ECWT | EXTERIOR CONTAINER WEIGHT | 9.00 POUNDS |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLONAZEPAM TABLETS USP 0.5 MG 100S BT |
| EXME | EXTERIOR CONTAINER CUBIC MEASURE | 1.000 CUBIC FEET |
| SUWT | UNIT OF ISSUE WEIGHT | 0.06 POUNDS |
| SUCB | UNIT OF ISSUE CUBE | 0.007 CUBIC FEET |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.500 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT |
| PKQT | INTERMEDIATE PACKAGE QUANTITY | 12 |
| FEAT | SPECIAL FEATURES | CLASS 4 |
| EXQT | EXTERIOR CONTAINER QUANTITY | 144 |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |